Related references
Note: Only part of the references are listed.ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors
Cheng-Po Huang et al.
CANCER LETTERS (2013)
Lung cancer stem cells: Progress and prospects
Amber Lundin et al.
CANCER LETTERS (2013)
Cisplatin Selects for Multidrug-Resistant CD133(+) Cells in Lung Adenocarcinoma by Activating Notch Signaling
Yu-Peng Liu et al.
CANCER RESEARCH (2013)
Aptamer Identification of Brain Tumor-Initiating Cells
Youngmi Kim et al.
CANCER RESEARCH (2013)
Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy
Toshio Kubo et al.
CANCER SCIENCE (2013)
Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties
Ngoc Bich Vu et al.
CYTOTECHNOLOGY (2013)
CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits
Se-Yeong Oh et al.
EUROPEAN JOURNAL OF CANCER (2013)
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
S. Catuogno et al.
ONCOGENE (2013)
Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
Martin P. Barr et al.
PLOS ONE (2013)
Fluorouracil selectively enriches stem-like cells in the lung adenocarcinoma cell line SPC
Mu-mu Shi et al.
TUMOR BIOLOGY (2013)
Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance
Csilla Hegedues et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Dual inhibitors of P-glycoprotein and tumor cell growth: (Re)discovering thioxanthones
Andreia Palmeira et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors
Gargi Ghosh et al.
BMC CANCER (2012)
Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment
Jeng-Long Hsieh et al.
CANCER LETTERS (2012)
Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446
Xiaofei Qiu et al.
CANCER LETTERS (2012)
Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer
Yi Zhang et al.
CANCER LETTERS (2012)
Cancer Stem Cells: Current Status and Evolving Complexities
Jane E. Visvader et al.
CELL STEM CELL (2012)
Personalized targeted therapy in advanced non-small cell lung cancer
P. C. MA
CLEVELAND CLINIC JOURNAL OF MEDICINE (2012)
Role of Insulin-Like Growth Factor-1 Signaling Pathway in Cisplatin-Resistant Lung Cancer Cells
Yunguang Sun et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
The Cancer Stem-Cell Hypothesis Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy
John D. O'Flaherty et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
Hee Yi et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2012)
Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy
Kazuhiko Shien et al.
LUNG CANCER (2012)
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
Michela Garofalo et al.
NATURE MEDICINE (2012)
Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma
Dong Liang et al.
MEDICAL ONCOLOGY (2012)
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
L. Sun et al.
ONCOGENE (2012)
The Side Population in Human Lung Cancer Cell Line NCI-H460 Is Enriched in Stem-Like Cancer Cells
Yang Shi et al.
PLOS ONE (2012)
Low Molecular Weight Heparin Ablates Lung Cancer Cisplatin-Resistance by Inducing Proteasome-Mediated ABCG2 Protein Degradation
Qi Niu et al.
PLOS ONE (2012)
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation
Giulia Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
S. Akunuru et al.
CELL DEATH & DISEASE (2012)
CD133+, CD166+CD44+, and CD24+CD44+Phenotypes Fail to Reliably Identify Cell Populations with Cancer Stem Cell Functional Features in Established Human Colorectal Cancer Cell Lines
Manuele Giuseppe Muraro et al.
STEM CELLS TRANSLATIONAL MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Involvement of NF-kappa B/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells
Q-Q Li et al.
CELL DEATH AND DIFFERENTIATION (2011)
New Uses for Old Drugs: Pharmacophore-Based Screening for the Discovery of P-Glycoprotein Inhibitors
Andreia Palmeira et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer
Ivan S. Donev et al.
CLINICAL CANCER RESEARCH (2011)
Pathology of Lung Cancer
William D. Travis
CLINICS IN CHEST MEDICINE (2011)
Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in Stem-Cell-Like Tumor Cells
Zhiyong Du et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
MicroRNA regulation of core apoptosis pathways in cancer
Raquel T. Lima et al.
EUROPEAN JOURNAL OF CANCER (2011)
Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells
Zi Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cancer stem cells: a new framework for the design of tumor therapies
Boyan K. Garvalov et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity
Munehide Nakatsugawa et al.
LABORATORY INVESTIGATION (2011)
Side population rather than CD133+ cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells
Jianjun Zhou et al.
MOLECULAR CANCER (2011)
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Alex Chang
LUNG CANCER (2011)
Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro
Julia Mihatsch et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
M. Saxena et al.
CELL DEATH & DISEASE (2011)
Enrichment of osteosarcoma stem cells by chemotherapy
Qing-Lian Tang et al.
Chinese Journal of Cancer (2011)
Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data
Caroline Rivera et al.
JOURNAL OF ONCOLOGY (2011)
Targeting theMechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis
Ryan Morrison et al.
JOURNAL OF ONCOLOGY (2011)
Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
C. D. Salcido et al.
BRITISH JOURNAL OF CANCER (2010)
PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-κB
H. Bark et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
James P. Sullivan et al.
CANCER RESEARCH (2010)
Cancer stem cells in solid tumors: elusive or illusive?
Yvonne Welte et al.
CELL COMMUNICATION AND SIGNALING (2010)
Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer
Dennis Shin-Shian Hsu et al.
CLINICAL CANCER RESEARCH (2010)
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Anna Maria Calcagno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Mechanisms of Stem Cell Self-Renewal
Shenghui He et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2009)
Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells
Xiangjiao Meng et al.
CANCER SCIENCE (2009)
Aldehyde dehydrogenase activity as a functional marker for lung cancer
Deniz Ucar et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
Qing-Quan Li et al.
CLINICAL CANCER RESEARCH (2009)
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
Giulia Bertolini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Characterization of a stem cell population in lung cancer A549 cells
Ji-Min Sung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis
Christine E. Eyler et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
Vera Levina et al.
PLOS ONE (2008)
Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
Yu-Chih Chen et al.
PLOS ONE (2008)
Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: Implications for predictive testing
Gabriela M. Almeida et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Identification and expansion of the tumorigenic lung cancer stem cell population
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
The hunt for cancer-initiating cells: a history stemming from leukemia
M. P. Buzzeo et al.
LEUKEMIA (2007)
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells
Maria M. Ho et al.
CANCER RESEARCH (2007)
Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
Margarita Gutova et al.
PLOS ONE (2007)
Drug therapy: Multidisciplinary management of lung cancer
A Spira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
